Equity Profile
Post-Earnings Recap
Dyne Therapeutics, Inc.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.33 | $2.19 | +14.50% |
| Revenue | — | $227M | — |
management commentary, guidance changes, and full analysis available with Pro.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
Nova Ltd. (NVMI) operates in the semiconductor materials and equipment sector, providing advanced solutions for the semiconductor industry....
EPS
Earnings per share is a key indicator of profitability and is closely watched by investors.
Revenue
Revenue growth reflects the company's ability to expand its market presence and meet demand.
Wall Street expectations, options signals, track record, and call prep available with Pro.